NCT01811238View on ClinicalTrials.gov

An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

July 31, 2013

Conditions
Spinal Disorders
Interventions
DRUG

Oxycodone/naloxone

Targin 5mg, 10mg, 20mg up to 40mg b.i.d

All Listed Sponsors
lead

Mundipharma Korea Ltd

INDUSTRY

NCT01811238 - An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders | Biotech Hunter | Biotech Hunter